Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoadjuvant Operable Breast Cancer
Interventions: DRUG: Fluorouracile|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Letrozole|DRUG: Palbociclib
Sponsor: UNICANCER
Collaborators: Pfizer|NanoString Technologies, Inc.